Simplified catechin-gallate inhibitors of HIV-1 reverse transcriptase (Q43759929)

26 November 2017

Simplified catechin-gallate inhibitors of HIV-1 reverse transcriptase (English)

1 reference

26 November 2017

Tillekeratne LM

1

1 reference

26 November 2017

Sherette A

2

1 reference

26 November 2017

Grossman P

3

1 reference

26 November 2017

Hupe L

4

1 reference

26 November 2017

Hupe D

5

1 reference

26 November 2017

Hudson RA

6

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

Bioorganic & Medicinal Chemistry Letters

26 November 2017

1 reference

26 November 2017

11

1 reference

26 November 2017

2763-2767

1 reference

26 November 2017

20

1 reference

Molecular targets for AIDS therapy

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900577-7

7 January 2021

The HIV-1 reverse transcription (RT) process as target for RT inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900577-7

7 January 2021

Protease inhibitors: current status and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900577-7

7 January 2021

Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900577-7

7 January 2021

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: strategies to overcome drug resistance development

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900577-7

7 January 2021

Novel compounds in preclinical/early clinical development for the treatment of HIV infections

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900577-7

7 January 2021

The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900577-7

7 January 2021

Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900577-7

7 January 2021

Plasma viremia as a sensitive indicator of the antiretroviral activity of L-697,661.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900577-7

7 January 2021

Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid polymerases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900577-7

7 January 2021

Simple Method for the Esterification of Carboxylic Acids

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900577-7

7 January 2021

Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900577-7

7 January 2021

Actinomycin D inhibition of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase and nucleocapsid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900577-7

7 January 2021

10.1016/S0960-894X(01)00577-7

Identifiers

DOI

1 reference

26 November 2017

1 reference